Allergan, Inc.

Allergan confirms Botox not involved in death of woman following treatment

Published in Medicine and Law Weekly, April 21st, 2006

Allergan, Inc., (AGN) has confirmed with local law enforcement authorities conducting an ongoing investigation that Botox (botulinum toxin type A) was not involved in the case of a woman who died following treatment with an unknown substance by an unlicensed practitioner in Monterey County, California.

"This unfortunate incident makes clear how important it is for consumers to seek out licensed, trained and qualified healthcare professionals when considering treatment with Botox and to verify that they are receiving authentic Botox and not an unlicensed botulinum toxin or alternative substance," said Douglas S. Ingram, Allergan's executive VP, general counsel and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2006-04-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry